✦ LIBER ✦

Practical Synthesis of NPY Antagonist Drug Candidates for Treatment of Obesity

✍ Scribed by Takahiro Itoh; Toshiaki Mase

Book ID: 102010008
Publisher: John Wiley and Sons
Year: 2007
Weight: 11 KB
Volume: 38
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200745240

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

Efficient Synthesis of a Highly Selectiv

Efficient Synthesis of a Highly Selective NPY-5 Receptor Antagonist: A Drug Candidate for the Treatment of Obesity

✍ Itoh, Takahiro; Kato, Shinji; Nonoyama, Nobuaki; Wada, Toshihiro; Maeda, Kenji; 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 113 KB

NPY-Ergic agents for the treatment of ob

NPY-Ergic agents for the treatment of obesity

✍ Ildikó Antal Zimányi; Graham S. Poindexter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 2 views

Rimonabant: an antagonist drug of the en

Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity

✍ Leite, Carlos E. (author);Mocelin, Clei A. (author);Petersen, Guilherme O. (auth 📂 Article 📅 2009 🏛 Polish Academy of Sciences 🌐 English ⚖ 128 KB

Rimonabant: an antagonist drug of the en

Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity

✍ Leite, Carlos E. (author);Mocelin, Clei A. (author);Petersen, Guilherme O. (auth 📂 Article 📅 2009 🏛 Polish Academy of Sciences 🌐 English ⚖ 128 KB

Discovery and Optimization of a Series o

Discovery and Optimization of a Series of Carbazole Ureas as NPY5 Antagonists for the Treatment of Obesity

✍ Block, Michael H.; Boyer, Scott; Brailsford, Wayne; Brittain, David R.; Carroll, 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 181 KB

Synthesis of isotopically labeled 2-pyri

Synthesis of isotopically labeled 2-pyridinyloxyisobutanoic acid, a building block for CB-1 inhibitors as drug candidates for obesity treatment

✍ Jonathan Z. Ho; Matthew P. Braun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB